These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11730317)

  • 21. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
    Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
    Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Guidelines for health surveillance of health care workers exposed to biological risks set up by the Italian Society for Occupational Health and Industrial Hygiene: application in health facilities of the Regional Health Administration--District No. 7, Ancona].
    Copertaro A; Barbaresi M; Bevilacqua G; Novelli AM; Aprile A;
    Med Lav; 2005; 96(1):52-62. PubMed ID: 15847108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of exposure to bloodborne pathogens.
    Gregson D
    J Can Dent Assoc; 2000 Nov; 66(10):544-5. PubMed ID: 12584773
    [No Abstract]   [Full Text] [Related]  

  • 24. External quality assessment for the detection of blood-borne viruses in plasma by nucleic acid amplification technology: the first human immunodeficiency virus and hepatitis B virus studies (HIV EQA/1 and HBV EQA/1) and the fifth hepatitis C virus study (HCV EQA/5).
    Pisani G; Cristiano K; Saldanha J; Wirz M; Bisso GM; Mele C; Gentili G;
    Vox Sang; 2004 Aug; 87(2):91-5. PubMed ID: 15355499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV, HBV, HCV, and syphilis co-infections among patients attending the STD clinics of district hospitals in Northern India.
    Hussain T; Kulshreshtha KK; Sinha S; Yadav VS; Katoch VM
    Int J Infect Dis; 2006 Sep; 10(5):358-63. PubMed ID: 16678462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of infection in health care workers following occupational exposure to a noninfectious or unknown source.
    Kuruuzum Z; Yapar N; Avkan-Oguz V; Aslan H; Ozbek OA; Cakir N; Yuce A
    Am J Infect Control; 2008 Dec; 36(10):e27-31. PubMed ID: 19084160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postexposure immunization and prophylaxis of bloodborne pathogens following a traumatic explosive event: preliminary recommendations.
    Subbarao I; Steinbrecher R; Tan L; Peleg K; Zeiger J; James JJ
    Disaster Med Public Health Prep; 2007 Nov; 1(2):106-9. PubMed ID: 18388637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PHS issues guidelines for treating occupational exposure to HIV. Public Health Service.
    NIAID AIDS Agenda; 1996 Sep; ():11. PubMed ID: 11363919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postexposure interventions to prevent infection with HBV, HCV, or HIV, and tetanus in people wounded during bombings and other mass casualty events--United States, 2008: recommendations of the Centers for Disease Control and Prevention and Disaster Medicine and Public Health Preparedness.
    Chapman LE; Sullivent EE; Grohskopf LA; Beltrami EM; Perz JF; Kretsinger K; Panlilio AL; Thompson ND; Ehrenberg RL; Gensheimer KF; Duchin JS; Kilmarx PH; Hunt RC
    Disaster Med Public Health Prep; 2008 Oct; 2(3):150-65. PubMed ID: 18677271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
    Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
    Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination.
    Sun HY; Ko WC; Tsai JJ; Lee HC; Liu CE; Wong WW; Su SC; Ho MW; Cheng SH; Yang CH; Lin YH; Miao WJ; Sheng WH; Hung CC
    Am J Gastroenterol; 2009 Apr; 104(4):877-84. PubMed ID: 19259078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology of hepatitis virus B and C.
    Dehesa-Violante M; Nuñez-Nateras R
    Arch Med Res; 2007 Aug; 38(6):606-11. PubMed ID: 17613351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA.
    McCormick MK; Dockter J; Linnen JM; Kolk D; Wu Y; Giachetti C
    J Clin Virol; 2006 Jul; 36(3):166-76. PubMed ID: 16427802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B virus, hepatitis C virus and other blood-borne infections in healthcare workers: guidelines for prevention and management in industrialised countries.
    FitzSimons D; François G; De Carli G; Shouval D; Prüss-Ustün A; Puro V; Williams I; Lavanchy D; De Schryver A; Kopka A; Ncube F; Ippolito G; Van Damme P
    Occup Environ Med; 2008 Jul; 65(7):446-51. PubMed ID: 18562683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States.
    Perumal V; Wang J; Thuluvath P; Choti M; Torbenson M
    Hum Pathol; 2006 Sep; 37(9):1211-6. PubMed ID: 16938527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?
    Rodríguez-Torres M; Gonzalez-Garcia J; Bräu N; Solá R; Moreno S; Rockstroh J; Smaill F; Mendes-Correa MC; DePamphilis J; Torriani FJ;
    J Med Virol; 2007 Jun; 79(6):694-700. PubMed ID: 17457912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panels.
    Assal A; Barlet V; Deschaseaux M; Dupont I; Gallian P; Guitton C; Morel P; van Drimmelen H; David B; Lelie N; De Micco P
    Transfusion; 2009 Feb; 49(2):301-10. PubMed ID: 19389212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.